Expression of Matrix Metalloproteinase 9/13（MMP-9/13）and Tissue Inhibitor of Metalloproteinase 1/2（TIMP-1/2）in Liver Fibrosis Induced by Porcine Serum and Xiayuxue Decoction on It

DU Guang-li; LIU Ping; WANG Lei; TAN Shan-zhong; LONG Ai-hua; MU Yong-ping; WANG Chun-shu

doi:10.13422/j.cnki.syfjx.2009.11.021

您当前的位置：

首页 >

文章列表页 >

Expression of Matrix Metalloproteinase 9/13（MMP-9/13）and Tissue Inhibitor of Metalloproteinase 1/2（TIMP-1/2）in Liver Fibrosis Induced by Porcine Serum and Xiayuxue Decoction on It

更新时间：2024-09-23

- Expression of Matrix Metalloproteinase 9/13（MMP-9/13）and Tissue Inhibitor of Metalloproteinase 1/2（TIMP-1/2）in Liver Fibrosis Induced by Porcine Serum and Xiayuxue Decoction on It
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 15, Issue 11, Pages: 48-51(2009)
- 作者机构：
  
  上海中医药大学
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2009.11.021
  CLC： R285.5
- Published：2009
- 稿件说明：
移动端阅览
[1]都广礼,刘平,王磊,谭善忠,龙爱华,慕永平,王春树.猪血清肝纤维化大鼠肝组织基质金属蛋白酶-9/13和基质金属蛋白酶组织抑制因子-1/2表达的动态变化及下瘀血汤对其影响[J].中国实验方剂学杂志,2009,15(11):48-51.

DU Guang-li, LIU Ping, WANG Lei, et al. Expression of Matrix Metalloproteinase 9/13（MMP-9/13）and Tissue Inhibitor of Metalloproteinase 1/2（TIMP-1/2）in Liver Fibrosis Induced by Porcine Serum and Xiayuxue Decoction on It[J]. Chinese journal of experimental traditional medical formulae, 2009, 15(11): 48-51.
[1]都广礼,刘平,王磊,谭善忠,龙爱华,慕永平,王春树.猪血清肝纤维化大鼠肝组织基质金属蛋白酶-9/13和基质金属蛋白酶组织抑制因子-1/2表达的动态变化及下瘀血汤对其影响[J].中国实验方剂学杂志,2009,15(11):48-51. DOI： 10.13422/j.cnki.syfjx.2009.11.021.

DU Guang-li, LIU Ping, WANG Lei, et al. Expression of Matrix Metalloproteinase 9/13（MMP-9/13）and Tissue Inhibitor of Metalloproteinase 1/2（TIMP-1/2）in Liver Fibrosis Induced by Porcine Serum and Xiayuxue Decoction on It[J]. Chinese journal of experimental traditional medical formulae, 2009, 15(11): 48-51. DOI： 10.13422/j.cnki.syfjx.2009.11.021.

摘要

目的:研究免疫性肝纤维化大鼠肝组织基质金属蛋白酶9/13和基质金属蛋白酶组织抑制因子1/2表达的动态变化及下瘀血汤对其影响

探讨下瘀血汤抗肝纤维化的机制。方法:猪血清腹腔复制大鼠肝纤维化模型

造模8周后ig下瘀血汤的流浸膏

用药4周后和在造模过程中的1、24、、8周动态处死大鼠

获取标本

检测指标。结果:MMP-2/9的高活性和TIMP-1的高表达贯穿于本模型的始终。MMP-9/13蛋白表达在肝纤维化发生发展过程中有先抑制后升高

再次抑制而后升高的反复过程

并受TIMP-1/2表达影响;下瘀血汤可以提高MMP-9活性

促进MMP-9/13而抑制TIMP-1

2表达。结论:该模型有MMP-9/13和TIMP-1/2表达的失衡;下瘀血汤可通过调控MMp-9/13和TIMP-1/2的表达

降解过度沉积的细胞外基质而发挥抗肝纤维化的作用。

Abstract

Objective:Changes of protein expression of MMP-9/13 and TIMP1/2 in fibrotic liver tissue induced by porcine serum and effect of Xiayuxue Decoction on it are investigated in this study to explore mechanism of Xiayuxue Decotion in reversing it.Methods:Liver fibrosis in rats was induced by intraperitoneal injection of porcine serum.After 8wk of modeling

rats were given Xiayuxue Decoction for 4 weeks.Rats were sacrificed and sample was obtained for determination at 1 wk

2 wk

4 wk

8 wk and the end of 12 wk of modeling for determination.Results:High activity of MMP-2/9 and high expression TIMP-1 characterizes this liver fibrosis model from beginning to the end.Decreased protein expression of MMP-9/13 in early stage and increased protein expression of MMP-9/13 in early stage and increased protein expression of MMP-9/13 affect by protein expression TIMP-1/2.Xiayuxue Decoction can increase activity of MMP-9

promote expression of MMP-9/13

inhibit expression of TIMP-1/2.Conclusions:Imbalanced MMP-9/13 and TIMP-1/2 expression is seen in this model.The anti-liver fibrosis mechanism of Xiayuxue Decoction is regulating MMP-9/13 and TIMP-1/2 expression to degrade excessive deposition of extracellular matrix.

关键词

Keywords

references

Views

290

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Relationship Between Traditional Medical Formulae and Syndrome Based Pharmacological Study of Xiayuxue Decoction against Porcine Serum Induced Liver Fibrosis in Rats

Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease：A Review

Clinical Efficacy of Gandou Fumu Granules in Intervention of Liver Fibrosis in WD Patients with Phlegm and Blood Stasis Syndrome and Effect on Cuproptosis-related Indicators

Gandouling Regulates PI3K/Akt/mTOR Autophagy Signaling Pathway via LncRNA H19 for Treatment of Wilson Disease Liver Fibrosis

Related Author

DU Guang-li

Liu Ping

WANG Lei

TAN Shan-zhong

LONG Ai-hua

MU Yong-ping

WANG Chun-shu

WANG Xiaojie

Related Institution

Henan General Hospital

The First Clinical Medical College of Henan University of Chinese Medicine

The First Affiliated Hospital of Henan University of Chinese Medicine

The First Affiliated Hospital of Anhui University of Chinese Medicine

Graduate School of Anhui University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰